CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Old Ayala Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Old Ayala Inc
1007 North Orange Street, 4th Floor
Phone: (857) 444-0553p:857 444-0553 WILMINGTON, DE  19802  United States Ticker: AYLAAYLA
Business Summary
Old Ayala ,Inc., formerly Ayala Pharmaceuticals, Inc., is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The Company's portfolio of product candidates, AL101 and AL102, targets the aberrant activation of the Notch pathway using gamma secretase inhibitors (GSIs).

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202212/31/2022YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board DavidSidransky 64 11/1/2017 11/1/2017
Chief Executive Officer Kenneth A.Berlin 58 10/18/2022 10/18/2022
Chief Financial Officer IgorGitelman 47 10/13/2022 10/13/2022
4 additional Officers and Directors records available in full report.

Business Names
Business Name
Advaxis, Inc.
Ayala Pharmaceuticals Inc
Ayala-Oncology Israel Ltd.
AYLA

General Information
Number of Employees: 14 (As of 12/31/2022)
Outstanding Shares: 14,080,383 (As of 12/31/2022)
Shareholders: 22
Stock Exchange: NASD
Federal Tax Id: 823578375
Fax Number: (302) 655-5049


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024